Planned Parenthood Caught Giving Trans Hormones to Minors

A new undercover investigation by Live Action has revealed that Planned Parenthood facilities in multiple states are willing to prescribe cross-sex hormones to minors – often without therapy, in-person evaluation, or parental consent. The investigation, released Wednesday, features a Live Action investigator posing as a 16-year-old girl seeking testosterone to begin a so-called “gender transition.” Staff at […]

The post Planned Parenthood Caught Giving Trans Hormones to Minors appeared first on LifeNews.com.

---

A new undercover investigation by Live Action has revealed that Planned Parenthood facilities in multiple states are willing to prescribe cross-sex hormones to minors – often without therapy, in-person evaluation, or parental consent.

The investigation, released Wednesday, features a Live Action investigator posing as a 16-year-old girl seeking testosterone to begin a so-called “gender transition.”

Staff at clinics in New York, Minnesota, and other states assured the minor that she could access the powerful hormone drugs with minimal oversight.

Click here to sign up for pro-life news alerts from LifeNews.com

At one New York facility, an employee told the caller that a parent did not need to be present during the entire appointment.

“At some point in the appointment, maybe, she doesn’t have to be in the examining room with you,” the staffer said, referring to the caller’s mother.

Other clinics confirmed that no therapy or psychological screening was required.

“You’re good to be seen here then. 16 and older,” a Minnesota employee said. “Nope,” she added when asked if therapy records were needed.

In several cases, facilities said prescriptions could be issued the day after a brief virtual consultation.

“The provider is gonna to send the prescription to your pharmacy the same day of your appointment,” said a New York staffer.

These revelations come amid continuous concern over Planned Parenthood’s promotion of hormone drugs to minors.

A 2025 Department of Health and Human Services (HHS) report identified Planned Parenthood as a “leading provider” of cross-sex hormones to adolescents. It warned that many recipients “have co-occurring psychiatric or neurodevelopmental conditions, rendering them especially vulnerable.”

“These dangerous drugs can sterilize, stunt growth, and leave lifelong scars,” said Live Action President Lila Rose. “This is not healthcare. It is child abuse, and it must be stopped.”

Despite the controversy, Planned Parenthood receives nearly $700 million annually in federal funding, a figure that rose under the Biden administration.

The Trump administration has taken steps to restrict this funding.

Last month, it froze $27.5 million in Title X grants to organizations under investigation for violating federal diversity, equity, and inclusion (DEI) mandates. Several Planned Parenthood affiliates were among the impacted groups.

“Planned Parenthood is fast-tracking vulnerable children into irreversible hormone treatments with almost no medical oversight,” Rose told Fox News Digital. “It’s time for Congress and the president to act and defund this abusive corporation.”

According to Fox News Digital, Republican lawmakers are considering a full termination of Planned Parenthood’s federal funding as part of a broader $1.5 trillion cost-cutting package.

Meanwhile, Live Action has launched a petition urging Americans to demand an end to taxpayer funding of Planned Parenthood.

“Our reporting proves three devastating facts,” said a Live Action spokesperson. “Planned Parenthood is giving trans drugs to minors (16-year-olds). No therapy or mental health evaluation is required. Minors can access the drugs the same day as their first (virtual) appointment.”

“When Americans learn Planned Parenthood is transing kids,” the group added, “their support for the organization collapses. This must be a turning point — we’re calling for the full defunding of Planned Parenthood.”

LifeNews Note: Elise DeGeeter writes for CatholicVote, where this column originally appeared.